The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 25, 1989

Filed:

Aug. 10, 1987
Applicant:
Inventors:

Bohdan J Kudryk, Little Ferry, NJ (US);

Michael E Wiebe, Stamford, CT (US);

Assignee:

The New York Blood Center, Inc., New York, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K / ; A61K / ; G01N / ; C12N / ;
U.S. Cl.
CPC ...
435-7 ; 530387 ; 530388 ; 435 68 ; 435 70 ; 4351722 ; 43524027 ; 435188 ; 424-11 ; 424 858 ; 436518 ; 436542 ; 436540 ; 436537 ; 436543 ; 436544 ; 436545 ; 935 95 ; 935104 ; 935108 ; 935110 ;
Abstract

Hybridoma for production of monoclonal antibody to an antigen found on the peptide fragment of the B.beta. chain of human fibrinogen or fibrin I containing amino acid residues 1-42. The hybridoma is formed by fusing an animal myeloma cell, e.g., mouse myeloma cell, with a splenocyte from an animal, e.g., a mouse, immunized with an NH.sub.2 -terminal of human fibrinogen or fibrin I. Hybridoma for production of monoclonal antibody to an antigen found on the peptide fragment of the B.beta. chain of human fibrin II containing amino acid residues 15-42. The hybridoma is formed by fusing an animal, e.g., mouse myeloma cell with a splenocyte from an animal, e.g., mouse, immunized with a NH.sub.2 -terminal of human fibrin II. Diagnostic and therapeutic uses of the monoclonal antibodies are also disclosed.


Find Patent Forward Citations

Loading…